Dr. Ivy Abraham
Claim this profileIngalls Memorial Hospital
Studies Cancer
Studies Breast Cancer
12 reported clinical trials
25 drugs studied
Area of expertise
1Cancer
Stage IV
HER2 positive
Stage III
2Breast Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Ivy Abraham is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Tisotumab Vedotin
for Cancer
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors and what side effects (unwanted effects) may occur. There are seven parts to this study. * In Part A, the treatment will be given to participants every 3 weeks (3-week cycles). * In Part B, participants will receive tisotumab vedotin on Days 1, 8, and 15 every 4-week cycle. * In Part C, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. * In Part D, participants will be given treatment on Day 1 of every 3-week cycle. Participants in Part D will get tisotumab vedotin with either: * Pembrolizumab or, * Pembrolizumab and carboplatin, or * Pembrolizumab and cisplatin * In Part E, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. * In Part F, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part F will get tisotumab vedotin with pembrolizumab. * In Part G, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part G will get tisotumab vedotin with pembrolizumab and carboplatin.
Recruiting1 award Phase 216 criteria
More about Ivy Abraham
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Ivy Abraham has experience with
- Pembrolizumab
- Olaparib
- Cediranib Maleate
- Durvalumab
- Carboplatin
- Paclitaxel
Breakdown of trials Ivy Abraham has run
Cancer
Breast Cancer
Serous Cystadenocarcinoma
Endometrioid Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ivy Abraham specialize in?
Ivy Abraham focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Ivy Abraham currently recruiting for clinical trials?
Yes, Ivy Abraham is currently recruiting for 6 clinical trials in Harvey Illinois. If you're interested in participating, you should apply.
Are there any treatments that Ivy Abraham has studied deeply?
Yes, Ivy Abraham has studied treatments such as Pembrolizumab, Olaparib, Cediranib Maleate.
What is the best way to schedule an appointment with Ivy Abraham?
Apply for one of the trials that Ivy Abraham is conducting.
What is the office address of Ivy Abraham?
The office of Ivy Abraham is located at: Ingalls Memorial Hospital, Harvey, Illinois 60426 United States. This is the address for their practice at the Ingalls Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.